-
Hi, thank you for the opportunity and congrats to the team on a very strong set of numbers. Sir, first question, did you see any impact of higher raw material prices in the first quarter? You spoke about being cautious given the geopolitical issues.
Read in transcript -
Got it , Nirav bhai . T hat is helpful. The second question is , if we look at the growth which was spelled out by Bhavin bhai on th e organic ex - Wokadin e domestic number. Now, Wokadin e was broadly about INR 28 crores, INR 30 crores in FY 26, and if I just take that extrapolation into the first quarter, Wokadin e sales seem to have come down at least on a Y - o - Y basis.
Read in transcript -
Got it, sir. T he other question is, sir, if you're not going to add any MRs in FY27. Now, given that you are demonstrating such strong growth, I understand the volatility on the raw material side, and there would also be some under - recoveries from the hormonal facility. W ould it be fair to assume that there can be meaningful operating leverage if I take a two - to - three - year view here on?
Read in transcript
Analyst questions
Alankar Garude
Kotak Bank
1Call
1Company
CORONA
All company callsCORONA Remedies Limited
CORONA Remedies Limited
10 Aug 2026